These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8625522)

  • 1. Distribution of activated complement, C3b, and its degraded fragments, iC3b/C3dg, in the colonic mucosa of ulcerative colitis (UC).
    Ueki T; Mizuno M; Uesu T; Kiso T; Nasu J; Inaba T; Kihara Y; Matsuoka Y; Okada H; Fujita T; Tsuji T
    Clin Exp Immunol; 1996 May; 104(2):286-92. PubMed ID: 8625522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody to tropomyosin isoform 5 and complement induce the lysis of colonocytes in ulcerative colitis.
    Ebert EC; Geng X; Bajpai M; Pan Z; Tatar E; Das KM
    Am J Gastroenterol; 2009 Dec; 104(12):2996-3003. PubMed ID: 19690525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of C3 in C3 glomerulopathy.
    Sethi S; Vrana JA; Fervenza FC; Theis JD; Sethi A; Kurtin PJ; Zhang Y; Smith RJH
    Nephrol Dial Transplant; 2017 Mar; 32(3):459-465. PubMed ID: 27507892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial deposition of immunoglobulin G1 and activated complement (C3b and terminal complement complex) in ulcerative colitis.
    Halstensen TS; Mollnes TE; Garred P; Fausa O; Brandtzaeg P
    Gastroenterology; 1990 May; 98(5 Pt 1):1264-71. PubMed ID: 1691118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface epithelium related activation of complement differs in Crohn's disease and ulcerative colitis.
    Halstensen TS; Mollnes TE; Garred P; Fausa O; Brandtzaeg P
    Gut; 1992 Jul; 33(7):902-8. PubMed ID: 1379568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced expression of decay accelerating factor and CD59/homologous restriction factor 20 on the colonic epithelium of ulcerative colitis.
    Uesu T; Mizuno M; Inoue H; Tomoda J; Tsuji T
    Lab Invest; 1995 May; 72(5):587-91. PubMed ID: 7538183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement Receptor 2 Based Immunoassay Measuring Activation of the Complement System at C3-Level in Plasma Samples From Mice and Humans.
    Halkjær L; Troldborg A; Pedersen H; Jensen L; Hansen AG; Hansen TK; Bjerre M; Østergaard JA; Thiel S
    Front Immunol; 2020; 11():774. PubMed ID: 32431705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation of residues in the C3dg region of human complement component C3 corresponding to a proposed binding site for complement receptor type 2 (CR2, CD21) does not abolish binding of iC3b or C3dg to CR2.
    Diefenbach RJ; Isenman DE
    J Immunol; 1995 Mar; 154(5):2303-20. PubMed ID: 7868901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3.
    Newman SL; Mikus LK
    J Exp Med; 1985 Jun; 161(6):1414-31. PubMed ID: 2409200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interplay between fibrinolysis and complement: plasmin cleavage of iC3b modulates immune responses.
    Foley JH; Peterson EA; Lei V; Wan LW; Krisinger MJ; Conway EM
    J Thromb Haemost; 2015 Apr; 13(4):610-8. PubMed ID: 25556624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
    Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
    J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of epithelial cell expressed C3 in the intestine - Relevance for the pathophysiology of inflammatory bowel disease?
    Sünderhauf A; Skibbe K; Preisker S; Ebbert K; Verschoor A; Karsten CM; Kemper C; Huber-Lang M; Basic M; Bleich A; Büning J; Fellermann K; Sina C; Derer S
    Mol Immunol; 2017 Oct; 90():227-238. PubMed ID: 28843904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C3b binding, but not its breakdown, is affected by the structure of the O-antigen polysaccharide in lipopolysaccharide from Salmonellae.
    Grossman N; Joiner KA; Frank MM; Leive L
    J Immunol; 1986 Mar; 136(6):2208-15. PubMed ID: 3950413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The apolipoprotein(a) moiety of lipoprotein(a) interacts with the complement activation fragment iC3b but does not functionally affect C3 activation or degradation.
    Seifert PS; Roth I; Zioncheck TF
    Atherosclerosis; 1992 Apr; 93(3):209-16. PubMed ID: 1534227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional and structural characterization of four mouse monoclonal antibodies to complement C3 with potential therapeutic and diagnostic applications.
    Subías Hidalgo M; Yébenes H; Rodríguez-Gallego C; Martín-Ambrosio A; Domínguez M; Tortajada A; Rodríguez de Córdoba S; Llorca O
    Eur J Immunol; 2017 Mar; 47(3):504-515. PubMed ID: 28083930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Related IgA1 and IgG producing cells in blood and diseased mucosa in ulcerative colitis.
    Thoree VC; Golby SJ; Boursier L; Hackett M; Dunn-Walters DK; Sanderson JD; Spencer J
    Gut; 2002 Jul; 51(1):44-50. PubMed ID: 12077090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of moxibustion with different duration on colonic epithelial structure, serum inflammatory cytokines, and intestinal mucosa inflammatory cell signal transduction pathways].
    Ma TM; Han Y; Ma XD; Zeng XX; Ge W
    Zhen Ci Yan Jiu; 2014 Feb; 39(1):20-6. PubMed ID: 24684107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial deposits of immunoglobulin G1 and activated complement co-localize with the "M(r) 40kD" putative auto-antigen in ulcerative colitis.
    Halstensen TS; Das KM; Brandtzaeg P
    Adv Exp Med Biol; 1995; 371B():1273-6. PubMed ID: 7502798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The requirement of localized, CR2-mediated, alternative pathway activation of complement for covalent deposition of C3 fragments on normal B cells.
    Olesen EH; Johnson AA; Damgaard G; Leslie RG
    Immunology; 1998 Feb; 93(2):177-83. PubMed ID: 9616366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opsonization of yeast cells with equine iC3b, C3b, and IgG.
    Gröndahl G; Johannisson A; Jensen-Waern M; Nilsson Ekdahl K
    Vet Immunol Immunopathol; 2001 Aug; 80(3-4):209-23. PubMed ID: 11457475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.